SPOTLIGHT -
EP. 1: Introduction: Review of CRPC Guideline Updates
EP. 2: Case Study: Treating High Risk CRPC
EP. 3: Role of Docetaxel in Newly Diagnosed Prostate Cancer
EP. 4: Initiation and Reintroduction of Docetaxel in Prostate Cancer
EP. 5: Case Study: Newly Diagnosed High-Risk Prostate Cancer
EP. 6: Importance of Detecting Early Metastasis in CRPC
EP. 7: Case Study: Newly Diagnosed Metastatic Prostate Cancer
EP. 8: Sequential and Combined Therapies in mCRPC
EP. 9: Case Study: Symptomatic, Progressing mCRPC
EP. 10: Performance Status in Progressive mCRPC
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
